Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Crohn's Disease; Rheumatoid Arthritis
Intervention:
Sponsors: University of California, San Diego; Organization of Teratology Information Specialists (OTIS); Abbott
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention: Drug: Rebif
Sponsor: EMD Serono
Not yet recruiting - verified March 2010
Condition: Multiple Sclerosis
Interventions: Drug: ONO-4641; Drug: ONO-4641; Drug: ONO-4641; Drug: ONO-4641 placebo
Sponsor: Ono Pharma
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Interventions: Behavioral: CI Therapy; Behavioral: CAM treatments
Sponsor: National Multiple Sclerosis Society
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: University of Rochester
Recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Behavioral: Diabetes related psychological counseling and education; Device: Continuous Glucose Monitor
Sponsors: University Hospital Case Medical Center; National Institute of Mental Health (NIMH)
Not yet recruiting - verified March 2010
Condition: Lupus Nephritis
Interventions: Drug: laquinimod 0.5mg + standard of care; Drug: laquinimod 1mg + standard of care; Other: placebo + standard of care
Sponsor: Teva Pharmaceutical Industries
Not yet recruiting - verified March 2010
Conditions: Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Polyneuropathy
Interventions: Drug: SB-509; Other: Saline
Sponsors: Sangamo Biosciences; Juvenile Diabetes Research Foundation
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: NN1250; Drug: insulin glargine; Drug: NN1250; Drug: insulin aspart
Sponsor: Novo Nordisk
Recruiting - verified March 2010
Condition: Sjogren's Syndrome
Intervention: Drug: FID 114657 (ORB Preserved Ocular Emulsion)
Sponsor: Alcon Research
Recruiting - verified March 2010
Condition: Systemic Lupus Erythematosus
Intervention:
Sponsors: North Shore Long Island Jewish Health System; National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: natalizumab; Drug: interferon beta 1-a; Drug: methylprednisolone; Other: IV placebo; Drug: glatiramer acetate
Sponsors: Biogen Idec; Elan Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention:
Sponsors: Biogen Idec; Elan Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention:
Sponsors: Biogen Idec; Elan Pharmaceuticals
Not yet recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention:
Sponsors: University of Alabama at Birmingham; Brigham and Women's Hospital; Duke University; Johns Hopkins University; North Shore Medical Center; Stanford University; University of California, San Francisco; University of Colorado, Denver; University of Nebraska; University of Pittsburgh
Not yet recruiting - verified February 2010
Condition: Diabetes Mellitus
Interventions: Device: Finesse; Device: Pen/Syringe (Usual injection device)
Sponsors: Calibra Medical, Inc.; Nancy Bohannon, MD, Med. Corp.; Henry Ford Health System; Northwestern University; University of Texas Southwestern Medical Center; Joslin Diabetes Center; International Diabetes Center at Park Nicollet
Recruiting - verified March 2010
Conditions: Wegener's Granulomatosis; Microscopic Polyangiitis; Churg Strauss Syndrome; Polyarteritis Nodosa; Giant Cell Arteritis; Takayasu Arteritis
Intervention:
Sponsors: University of Oxford; American College of Rheumatology; The European League Against Rheumatism (EULAR); The Vasculitis foundation
Not yet recruiting - verified February 2010
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Eltrombopag; Drug: Eltrombopag
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Condition: Type 1 Diabetes
Interventions: Procedure: Isolated Pancreas Transplant; Drug: Intensive Insulin Therapy
Sponsor: Nantes University Hospital
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: SAR153191(REGN88); Drug: placebo
Sponsors: Sanofi-Aventis; Regeneron Pharmaceuticals
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: CP-690,550; Drug: Atorvastatin; Drug: CP-690,550; Drug: Atorvastatin Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo; Drug: VX-509; Drug: VX-509; Drug: VX-509; Drug: VX-509
Sponsor: Vertex Pharmaceuticals Incorporated
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: LY2605541; Drug: Insulin glargine
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra]
Sponsor: Hoffmann-La Roche
Not yet recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: Disease-modifying antirheumatic drug
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention: Drug: Betaseron (Interferon beta-1b, BAY86-5046)
Sponsor: Bayer
Recruiting - verified March 2010
Conditions: Multiple Sclerosis; Vitamin D Deficiency
Interventions: Dietary Supplement: Cholecalciferol; Dietary Supplement: Cholecalciferol
Sponsor: Johns Hopkins University
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Intervention: Drug: CP 690,550 oral solutions
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Conditions: Arthritis; Arthritis, Rheumatoid; Autoimmune Diseases
Interventions: Drug: golimumab; Drug: golimumab or placebo; Drug: golimumab or placebo
Sponsors: Centocor, Inc.; Schering-Plough
Recruiting - verified February 2010
Condition: Active Rheumatoid Arthritis
Intervention: Drug: SBI-087
Sponsor: Wyeth
Recruiting - verified February 2010
Conditions: Arthritis; Rheumatoid Arthritis
Interventions: Biological: CDP6038; Biological: CDP6038; Biological: CDP6038; Biological: CDP6038; Biological: CDP6038; Biological: CDP6038; Other: Placebo IV; Other: Placebo SC
Sponsor: UCB, Inc.
Recruiting - verified March 2010
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: ACT-128800; Drug: Placebo
Sponsor: Actelion
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: tociliumab; Drug: methotrexate
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: INGAP Peptide; Drug: INGAP Peptide; Drug: Placebo
Sponsor: Exsulin Corporation
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Biological: Placebo; Biological: Certolizumab pegol
Sponsor: UCB, Inc.
Recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: INSULIN GLARGINE (HOE901); Drug: Neutral Protamine Hagedorn (NPH) insulin
Sponsor: Sanofi-Aventis
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Interventions: Drug: AGEE cream; Drug: 1% Steroid Cream; Drug: topical placebo cream with no active ingredients
Sponsors: University of Nebraska; Teva Pharmaceutical Industries
Not yet recruiting - verified February 2010
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: tocilizumab [RoActemra]; Drug: tocilizumab [RoActemra]; Drug: placebo; Drug: NSAIDs, corticosteroids, methotrexate
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: CP-690,550 + methotrexate; Drug: Placebo + Methotrexate
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: placebo; Biological: golimumab; Biological: golimumab; Biological: golimumab
Sponsors: Centocor, Inc.; Schering-Plough
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Biological: LY2439821; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Conditions: CIDP; Chronic Inflammatory Demyelinating Polyneuropathy
Intervention: Drug: lipoic acid
Sponsors: Oregon Health and Science University; Collins Medical Trust
Recruiting - verified August 2009
Condition: Systemic Lupus Erythematosus
Interventions: Drug: placebo; Drug: rontalizumab
Sponsor: Genentech
Recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550; Drug: Placebo; Drug: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: AMG 827 70 mg; Drug: AMG 827 140 mg; Drug: AMG 827 210 mg; Drug: Placebo
Sponsor: Amgen
Recruiting - verified March 2010
Conditions: Multiple Sclerosis; Spinal Cord Injury
Interventions: Behavioral: Motivational interviewing; Behavioral: Education
Sponsor: University of Washington
Recruiting - verified February 2010
Conditions: Type 1 Diabetes; Eating Disorder
Intervention:
Sponsors: Park Nicollet Institute; International Diabetes Center at Park Nicollet; Park Nicollet Eating Disorder Institute; Park Nicollet Foundation
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Interventions: Behavioral: Self-management intervention; Behavioral: Education
Sponsor: University of Washington
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: PF-04171327 10 mg; Other: Prednisone Placebo; Drug: PF-04171327 25 mg; Other: Prednisone Placebo; Drug: Prednisone 5 mg; Other: Placebo for PF-04171327; Other: Placebo; Other: Placebo for PF-04171327
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Abatacept; Drug: Adalimumab
Sponsor: Bristol-Myers Squibb
Recruiting - verified December 2009
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: Teplizumab (MGA031); Drug: Placebo
Sponsors: MacroGenics; Eli Lilly and Company
Recruiting - verified March 2010
Conditions: Thrombocytopenia; Idiopathic Thrombocytopenic Purpura
Intervention: Biological: romiplostim
Sponsor: Amgen
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: LX3305 low dose; Drug: LX3305 mid dose; Drug: LX3305 high dose; Drug: Placebo
Sponsor: Lexicon Pharmaceuticals
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: tocilizumab [RoActemra]; Drug: Nonbiologic DMARDs of investigator's choice
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: LY2127399; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Conditions: Spinal Cord Injuries; Multiple Sclerosis; Stroke
Intervention:
Sponsor: Department of Veterans Affairs
Recruiting - verified February 2010
Conditions: Multiple Sclerosis; Systemic Lupus Erythematosus
Intervention: Procedure: Nonmyeloablative allogeneic stem cell transplant
Sponsor: Duke University
Recruiting - verified February 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550; Drug: Placebo; Drug: Placebo
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: CP 690,550; Drug: CP-690,550; Other: Placebo; Other: Placebo; Biological: Biologic TNFi
Sponsor: Pfizer
Recruiting - verified March 2010
Conditions: Polymyalgia Rheumatica; Rheumatoid Arthritis; Rheumatic Disease
Intervention:
Sponsor: Lahey Clinic
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Placebo; Drug: dose level 1; Drug: dose level 2; Drug: dose level 3; Drug: dose level 4
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention: Other: Single-Use Autoinjector with a Pre-Filled Liquid Avonex Syringe
Sponsor: Biogen Idec
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention: Drug: Glatiramer Acetate, IFN-beta 1a (IM), IFN-beta 1a (Subcu), and IFN-beta 1b
Sponsor: Teva Pharmaceutical Industries
Recruiting - verified March 2010
Conditions: Degenerative Joint Disease; Osteoarthritis; Rheumatoid Arthritis; Traumatic Arthritis
Intervention: Device: 3DKnee™ System
Sponsor: Encore Medical, L.P.
Recruiting - verified March 2010
Conditions: Eating Disorder; Type 1 Diabetes
Intervention: Behavioral: ED/DM Support Group
Sponsors: Park Nicollet Institute; International Diabetes Center at Park Nicollet; Park Nicollet Eating Disorder Institute; Park Nicollet Foundation
Recruiting - verified February 2010
Conditions: Lupus; Nephritis; Systemic Lupus Erythematosus
Intervention: Drug: AMG 811
Sponsor: Amgen
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: methotrexate; Drug: placebo
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: infliximab; Drug: methotrexate; Drug: methylprednisolone; Drug: ocrelizumab; Drug: sham
Sponsor: Genentech
Recruiting - verified February 2010
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib; Drug: Naproxen
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Systemic Lupus Erythematosus (SLE)
Intervention: Drug: Rapamycin
Sponsors: State University of New York - Upstate Medical University; Wyeth
Recruiting - verified February 2010
Condition: Systemic Lupus Erythematosus
Interventions: Other: Sugar Pill; Drug: N-acetylcysteine; Drug: N-acetylcysteine; Drug: N-acetylcysteine; Drug: N-acetylcysteine
Sponsor: State University of New York - Upstate Medical University
Recruiting - verified February 2010
Conditions: Lupus Nephritis; Lupus Erythematosus, Systemic
Interventions: Drug: Abatacept; Drug: cyclophosphamide; Drug: azathioprine; Drug: prednisone; Drug: abatacept placebo; Drug: azathioprine placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Interventions: Drug: Duloxetine HCI; Drug: Placebo
Sponsor: Eli Lilly and Company
Recruiting - verified February 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Drug: rhGAD65; Drug: rhGAD65; Drug: Placebo
Sponsor: Diamyd Therapeutics AB
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: Curcumin (Longvida™)
Sponsor: University of California, Los Angeles
Recruiting - verified September 2008
Condition: Rheumatoid Arthritis
Intervention: Drug: tocilizumab [RoActemra]
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Conditions: Osteoarthritis; Avascular Necrosis; Rheumatoid Arthritis
Intervention: Device: Cormet Hip Resurfacing
Sponsor: Corin
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra]; Drug: Standard anti-rheumatic treatment
Sponsor: Hoffmann-La Roche
Recruiting - verified February 2010
Condition: Rheumatoid Arthritis
Intervention: Drug: CNTO 136
Sponsor: Centocor, Inc.
Recruiting - verified February 2010
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib; Drug: nsNSAIDs
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Drug: Sulfasalazine
Sponsor: Pfizer
Not yet recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention: Drug: INFNb-1b
Sponsor: The University of North Carolina, Chapel Hill
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Interventions: Drug: CS-0777 tablets; Drug: CS-0777 tablets; Drug: CS-0777 tablets
Sponsor: Daiichi Sankyo Inc.
Recruiting - verified March 2010
Condition: Rheumatoid Arthritis
Interventions: Drug: Liquid Certolizumab pegol; Drug: Liquid Certolizumab pegol; Other: Placebo; Drug: Methotrexate
Sponsor: UCB, Inc.
Recruiting - verified March 2010
Conditions: Secondary Progressive Multiple Sclerosis; Relapsing Forms of Multiple Sclerosis
Interventions: Drug: natalizumab; Other: standard of care
Sponsors: Biogen Idec; Elan Pharmaceuticals
Recruiting - verified February 2010
Conditions: Islet Cell Transplantation; Type 1 Diabetes
Intervention: Procedure: Islet cell transplantation
Sponsors: Baylor Research Institute; Baylor University
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: IL-2; Drug: sirolimus
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified February 2010
Condition: Focal Segmental Glomerulosclerosis (FSGS)
Intervention: Drug: rituximab
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Genentech
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Antithymocyte globulin; Drug: Placebo
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network
Recruiting - verified January 2010
Condition: Chronic Idiopathic Thrombocytopenic Purpura
Interventions: Biological: Gammaplex, intravenous immunoglobulin; Biological: Gammaplex; Biological: Gammaplex
Sponsor: Bio Products Laboratory
Recruiting - verified March 2010
Condition: Type 1 Diabetes Mellitus
Interventions: Procedure: Islet transplant; Drug: Belatacept; Drug: Daclizumab or Basiliximab; Drug: Mycophenolate Mofetil
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2010
Condition: Type 1 Diabetes Mellitus
Intervention: Drug: Otelixizumab
Sponsors: Tolerx Inc.; Juvenile Diabetes Research Foundation
Recruiting - verified June 2009
Conditions: Multiple Sclerosis; Transverse Myelitis; Neuromyelitis Optica; Acute Disseminated Encephalomyelitis; Optic Neuritis
Intervention:
Sponsor: Accelerated Cure Project for Multiple Sclerosis
Recruiting - verified March 2010
Condition: Systemic Lupus Erythematosus
Interventions: Drug: steroids (prednisone or prednisolone) + MMF; Drug: abatacept; Drug: abatacept
Sponsor: Bristol-Myers Squibb
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Intervention: Other: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Arthritis, Rheumatoid
Interventions: Drug: CP-690,550; Drug: CP-690,550
Sponsor: Pfizer
Recruiting - verified March 2010
Condition: Lupus Nephritis
Interventions: Drug: mycophenolate mofetil [CellCept]; Drug: Cyclophosphamide; Drug: mycophenolate mofetil [CellCept]; Drug: Azathioprine
Sponsors: Hoffmann-La Roche; Aspreva Pharmaceuticals
Recruiting - verified February 2010
Condition: Idiopathic Thrombocytopenic Purpura
Intervention: Drug: eltrombopag olamine (SB-497115-GR)
Sponsor: GlaxoSmithKline
Recruiting - verified February 2010
Conditions: Arthritis, Rheumatoid; Osteoarthritis
Interventions: Drug: celecoxib; Drug: Ibuprofen; Drug: Naproxen
Sponsors: Pfizer; The Cleveland Clinic
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified February 2010
Condition: Multiple Sclerosis
Intervention: Procedure: Hematopoietic Stem Cell Therapy
Sponsors: Northwestern University; Rush University Medical Center; University of Calgary; University of Sao Paulo
Recruiting - verified March 2010
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Allogenic islet cells (human, U. Chicago); Procedure: Intraportal infusion of islet cells
Sponsor: University of Chicago
Recruiting - verified February 2010
Conditions: Autoimmune Disease; Congenital Adrenal Hyperplasia; Healthy; Mental Disorder Diagnosed in Childhood; Neurologic Manifestations
Intervention:
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified November 2009
Conditions: Sjogren's Syndrome; Xerostomia
Intervention:
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR)
Recruiting - verified January 2009
All Categories ... by Medical Condition » ... Chronic Illness » ... Auto-Immune Disorders 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
